Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer
Cristina Sarasqueta,Mª Victoria Zunzunegui,José María Enríquez Navascues,Arrate Querejeta,Carlos Placer,Amaia Perales,Nerea Gonzalez,Urko Aguirre,Marisa Baré,Antonio Escobar,José María Quintana,Jose María Quintana López,Marisa Baré Mañas,Maximino Redondo Bautista,Eduardo Briones Pérez de la Blanca,Nerea Fernández de Larrea Baz,Cristina Sarasqueta Eizaguirre,Antonio Escobar Martínez,Francisco Rivas Ruiz,Maria M. Morales-Suárez-Varela,Juan Antonio Blasco Amaro,Isabel del Cura González,Inmaculada Arostegui Madariaga,Amaia Bilbao González,Nerea González Hernández,Susana García-Gutiérrez,Iratxe Lafuente Guerrero,Urko Aguirre Larracoechea,Miren Orive Calzada,Josune Martin Corral,Ane Antón-Ladislao,Núria Torà,Marina Pont,María Purificación Martínez del Prado,Alberto Loizate Totorikaguena,Ignacio Zabalza Estévez,José Errasti Alustiza,Antonio Z. Gimeno García,Santiago Lázaro Aramburu,Mercè Comas Serrano,Jose María Enríquez Navascues,Carlos Placer Galán,Amaia Perales Antón,Iñaki Urkidi Valmaña,Jose María Erro Azkárate,Enrique Cormenzana Lizarribar,Adelaida Lacasta Muñoa,Pep Piera Pibernat,Elena Campano Cuevas,Ana Isabel Sotelo Gómez,Segundo Gómez-Abril,F. Medina-Cano,Julia Alcaide,Arturo Del Rey-Moreno,Manuel Jesús Alcántara,Rafael Campo,Alex Casalots,Carles Pericay,Maria José Gil,Miquel Pera,Pablo Collera,Josep Alfons Espinàs,Mercedes Martínez,Mireia Espallargues,Caridad Almazán,Paula Dujovne Lindenbaum,José María Fernández-Cebrián,Rocío Anula Fernández,Julio Mayol Martínez,Ramón Cantero Cid,Héctor Guadalajara Labajo,María Alexandra Heras Garceau,Damián García Olmo,Mariel Morey Montalvo,
DOI: https://doi.org/10.1186/s12885-020-07195-4
IF: 4.638
2020-08-14
BMC Cancer
Abstract:Abstract Background Few studies have examined gender differences in the clinical management of rectal cancer. We examine differences in stage at diagnosis and preoperative radiotherapy in rectal cancer patients. Methods A prospective cohort study was conducted in 22 hospitals in Spain including 770 patients undergoing surgery for rectal cancer. Study outcomes were disseminated disease at diagnosis and receiving preoperative radiotherapy. Age, comorbidity, referral from a screening program, diagnostic delay, distance from the anal verge, and tumor depth were considered as factors that might explain gender differences in these outcomes. Results Women were more likely to be diagnosed with disseminated disease among those referred from screening (odds ratio, confidence interval 95% (OR, CI = 7.2, 0.9–55.8) and among those with a diagnostic delay greater than 3 months (OR, CI = 5.1, 1.2–21.6). Women were less likely to receive preoperative radiotherapy if they were younger than 65 years of age (OR, CI = 0.6, 0.3–1.0) and if their tumors were cT3 or cT4 (OR, CI = 0.5, 0.4–0.7). Conclusions The gender-specific sensitivity of rectal cancer screening tests, gender differences in referrals and clinical reasons for not prescribing preoperative radiotherapy in women should be further examined. If these gender differences are not clinically justifiable, their elimination might enhance survival.
oncology